According to NGM Biopharmaceuticals's latest financial reports the company's current revenue (TTM) is $4.41 M.
In 2022 the company made a revenue of $55.33 M a decrease over the years 2021 revenue that were of $77.88 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $4.41 M | -92.02% |
2022 | $55.33 M | -28.95% |
2021 | $77.88 M | -10.86% |
2020 | $87.36 M | -15.62% |
2019 | $0.10 B | -4.71% |
2018 | $0.10 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | $0.79 B | 18,002.85% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | $0.22 M | -94.88% | ๐บ๐ธ USA |